New Owner
Actelion Pharmaceuticals - Ceptaris Therapeutics
Actelion Pharmaceuticals acquires Ceptaris Therapeutics
Announced: July 31, 2013
Closed: September 19, 2013
Type: Acquisition
Disposition: Combined
Status: Complete
Amount: $ 250,000,000